DE3869630D1 - 6-beta(substituierte)-(s)-hydroxymethylpenicillansaeure und deren derivate. - Google Patents

6-beta(substituierte)-(s)-hydroxymethylpenicillansaeure und deren derivate.

Info

Publication number
DE3869630D1
DE3869630D1 DE8888300425T DE3869630T DE3869630D1 DE 3869630 D1 DE3869630 D1 DE 3869630D1 DE 8888300425 T DE8888300425 T DE 8888300425T DE 3869630 T DE3869630 T DE 3869630T DE 3869630 D1 DE3869630 D1 DE 3869630D1
Authority
DE
Germany
Prior art keywords
beta
derivatives
substituted
residue
hydroxymethylpenicillanic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888300425T
Other languages
English (en)
Inventor
Yuhpyng Liang Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE3869630D1 publication Critical patent/DE3869630D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE8888300425T 1987-01-27 1988-01-20 6-beta(substituierte)-(s)-hydroxymethylpenicillansaeure und deren derivate. Expired - Fee Related DE3869630D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US731987A 1987-01-27 1987-01-27

Publications (1)

Publication Number Publication Date
DE3869630D1 true DE3869630D1 (de) 1992-05-07

Family

ID=21725481

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888300425T Expired - Fee Related DE3869630D1 (de) 1987-01-27 1988-01-20 6-beta(substituierte)-(s)-hydroxymethylpenicillansaeure und deren derivate.

Country Status (25)

Country Link
EP (1) EP0276942B1 (de)
JP (1) JPS63246384A (de)
KR (1) KR900005050B1 (de)
CN (1) CN1014710B (de)
AT (1) ATE74359T1 (de)
AU (2) AU590142B2 (de)
CA (1) CA1288091C (de)
DD (1) DD279882A5 (de)
DE (1) DE3869630D1 (de)
DK (1) DK36788A (de)
ES (1) ES2031589T3 (de)
FI (1) FI880334A (de)
GR (1) GR3004460T3 (de)
HU (1) HU205765B (de)
IE (1) IE60348B1 (de)
IL (1) IL85167A (de)
MY (1) MY102312A (de)
NO (1) NO172493C (de)
NZ (1) NZ223296A (de)
PH (1) PH24478A (de)
PL (2) PL159842B1 (de)
PT (1) PT86613B (de)
SU (2) SU1591812A3 (de)
YU (2) YU46436B (de)
ZA (1) ZA88514B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3869630D1 (de) * 1987-01-27 1992-05-07 Pfizer 6-beta(substituierte)-(s)-hydroxymethylpenicillansaeure und deren derivate.
AU5617398A (en) * 1996-12-30 1998-07-31 Beacon Laboratories L.L.C. Tricarboxylic acid-containing oxyalkyl esters and uses thereof
GB0128052D0 (en) * 2001-11-22 2002-01-16 Drug Discovery Lab As Compounds
US8187727B2 (en) 2005-07-22 2012-05-29 Lg Chem, Ltd. Imidazole derivatives, preparation method thereof and organic electronic device using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4272439A (en) * 1978-06-02 1981-06-09 Schering Corporation 6-(Substituted-hydroxymethylene penams)
US4304779A (en) * 1979-05-09 1981-12-08 Schering Corporation 6-(Nitrogen-containing heterocyclic)hydroxymethylpenicillanic acids, compounds related thereto and processes for their preparation
US4287181A (en) * 1979-10-22 1981-09-01 Pfizer Inc. Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors
GR77151B (de) * 1982-01-11 1984-09-07 Prizer
EP0150984B1 (de) * 1984-01-30 1991-09-11 Pfizer Inc. 6-(substituierte) Methylen-Penicillansäure und 6-(substituierte) Hydroxymethyl-Penicillansäure und deren Derivate
DD247677A5 (de) * 1984-01-30 1987-07-15 ������@���Kk�� Verfahren zur herstellung von 6-(subst.)-methylenpenicillan- und 6-(subst.)-hydroxymehtylpenicillansaeure und deren derivaten
DE3869630D1 (de) * 1987-01-27 1992-05-07 Pfizer 6-beta(substituierte)-(s)-hydroxymethylpenicillansaeure und deren derivate.

Also Published As

Publication number Publication date
NZ223296A (en) 1989-10-27
CN1014710B (zh) 1991-11-13
DK36788D0 (da) 1988-01-26
PH24478A (en) 1990-07-18
IE60348B1 (en) 1994-06-29
DD279882A5 (de) 1990-06-20
PL159842B1 (pl) 1993-01-29
GR3004460T3 (de) 1993-03-31
IE880197L (en) 1988-07-27
FI880334A0 (fi) 1988-01-26
IL85167A (en) 1994-01-25
KR880009030A (ko) 1988-09-13
AU590142B2 (en) 1989-10-26
YU46436B (sh) 1993-10-20
ZA88514B (en) 1989-09-27
PL270301A1 (en) 1988-12-08
NO880297L (no) 1988-07-28
HUT47118A (en) 1989-01-30
PT86613B (pt) 1991-12-31
PT86613A (pt) 1988-02-01
ATE74359T1 (de) 1992-04-15
AU613821B2 (en) 1991-08-08
KR900005050B1 (en) 1990-07-19
ES2031589T3 (es) 1992-12-16
SU1591812A3 (ru) 1990-09-07
NO172493B (no) 1993-04-19
NO880297D0 (no) 1988-01-25
DK36788A (da) 1988-09-23
JPS63246384A (ja) 1988-10-13
CN88100588A (zh) 1988-08-10
YU47020B (sh) 1994-11-15
YU14488A (en) 1990-02-28
EP0276942B1 (de) 1992-04-01
SU1681730A3 (ru) 1991-09-30
EP0276942A1 (de) 1988-08-03
FI880334A (fi) 1988-07-28
YU124389A (en) 1990-12-31
AU1074388A (en) 1988-07-28
NO172493C (no) 1993-07-28
PL161601B1 (pl) 1993-07-30
IL85167A0 (en) 1988-07-31
MY102312A (en) 1992-05-28
CA1288091C (en) 1991-08-27
HU205765B (en) 1992-06-29
AU4883290A (en) 1990-05-17

Similar Documents

Publication Publication Date Title
ES2147836T3 (es) Derivados de 4,5-diariloxazol.
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
HU9201033D0 (en) Tiazolidinone- and oxazolidinone derivatives, process for their production, and for the production of medical preparations containing them as active agents
DE3869630D1 (de) 6-beta(substituierte)-(s)-hydroxymethylpenicillansaeure und deren derivate.
DE3876712T2 (de) Antianaerobe naphthyridinverbindungen.
EP0231087A3 (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
ATE111468T1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und antibakterielle mittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee